“…The preparation of retinal sections, immunofluorescent labeling of retinal sections, and quantification of immunoreactive cells were performed as described previously (Mo et al, 2004;Li et al, 2005). The following primary antibodies were used: anti-tyrosine hydroxylase (TH) (sheep polyclonal; Millipore Bioscience Research Reagents, Temecula, CA); anti-syntaxin (mouse monoclonal; Sigma St. Louis, MO); anti--gal (rabbit polyclonal; Cappel Laboratories, Durham, NC); anti-GABA (rabbit polyclonal; Sigma); anti-GABA transporter 1 (GAT-1) (rabbit polyclonal; Millipore Bioscience Research Reagents); anti-calbindin-D28K (rabbit polyclonal; Swant, Bellizona, Switzerland); anti-Neurod1 (neurogenic differentiation 1) (mouse monoclonal and goat polyclonal; Santa Cruz Biotechnology, Santa Cruz, CA); anti-Lim1/2 (mouse monoclonal; Developmental Studies Hybridoma Bank, University of Iowa, Iowa City, IA); anti-Brn3a (mouse monoclonal; Millipore Bioscience Research Reagents); anti-Brn3b (goat polyclonal; Santa Cruz Biotechnology); anti-Brn3c (rabbit polyclonal) (Xiang et al, 1995); anti-retinoid X receptor ␥ (RXR␥) (rabbit polyclonal; Santa Cruz Biotechnology); anti-Pax6 (paired box gene 6) (rabbit polyclonal; Millipore Bioscience Research Reagents); anti-GFP [rabbit polyclonal (MBL International, Woburn, MA); goat polyclonal (Abcam, Cambridge, MA)]; anti-recoverin (rabbit polyclonal) (Dizhoor et al, 1991); anti-glycine transporter 1 (GLYT1) (goat polyclonal; Millipore Bioscience Research Reagents); anti-Chx10 (ceh-10 homeodomain containing homolog) (sheep polyclonal; Exalpha Biologicals, Maynard, MA); and anti-protein kinase C␣ (PKC␣) (mouse monoclonal; GE Healthcare, Little Chalfont, UK).…”